CS logo
small CS logo
Saint Joseph Radiation Oncology Resource Center

Lexington, Kentucky, United States
Oncologist in Lexington, Kentucky
701 Bob-O-Link Dr, Lexington, KY 40504

About Saint Joseph Radiation Oncology Resource Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Saint Joseph Radiation Oncology Resource Center


During the past decade, Saint Joseph Radiation Oncology Resource Center conducted 145 clinical trials. In the 10-year time frame, 145 clinical trials started and 48 clinical trials were completed, i.e. on average, 33.1% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 44 clinical trials were completed. i.e. 72.1% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Saint Joseph Radiation Oncology Resource Center" #1 sponsor was "National Cancer Institute (NCI)" with 81 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Radiation Oncology Resource Center" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

Clinical Trials Conditions at Saint Joseph Radiation Oncology Resource Center


According to Clinical.Site data, the most researched conditions in "Saint Joseph Radiation Oncology Resource Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Invasive Breast Carcinoma" (7 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Saint Joseph Radiation Oncology Resource Center" in a lesser frequency.

Clinical Trials Intervention Types at Saint Joseph Radiation Oncology Resource Center


Most popular intervention types in "Saint Joseph Radiation Oncology Resource Center" are "Drug" (131 trials), "Other" (102 trials), "Biological" (77 trials), "Procedure" (47 trials) and "Radiation" (21 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (43 trials), "Computed Tomography" (28 trials), "Nivolumab" (28 trials) and "Questionnaire Administration" (28 trials). Other intervention names were less common.

Clinical Trials Genders at Saint Joseph Radiation Oncology Resource Center


The vast majority of trials in "Saint Joseph Radiation Oncology Resource Center" are 138 trials for "All" genders, 29 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at Saint Joseph Radiation Oncology Resource Center


Currently, there are NaN active trials in "Saint Joseph Radiation Oncology Resource Center". undefined are not yet recruiting, 59 are recruiting, 83 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Saint Joseph Radiation Oncology Resource Center, 3 suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Saint Joseph Radiation Oncology Resource Center, 3 "Phase 1" clinical trials were conducted, 83 "Phase 2" clinical trials and 85 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".